CHS/Bayer ADVANCE Canada Research Program
Canadian Hemophilia Society (CHS)
UM Funding ID
FD03330
Sponsor
Canadian Hemophilia Society (CHS)
Category
Canadian Funding Opportunities
Description
The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population.
Funding up to $60,000 available for up to one year.
Results Announced: March 2024
VPRI Contact
Michelina Violi
Research Grants Specialist (Health & International)Michelina [dot] .Violi [at] @umanitoba [dot] .ca
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 21-Nov-2023 4:30 pm CST | 30-Nov-2023 |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.